Key facts
- Notable investors include Incubando Salud, SF500, Sparklab (Argentina).
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Gameet
- ·The full record, as it builds
Funding rounds
No funding rounds for Gameet are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gameet
Operator of a biotechnology company intended to empower fertility clinics with innovative technology that improves outcomes and provides a more certain path to parenthood. The company offers a micro-device that emulates natural sperm selection and maturation processes, enabling customers, fertility clinics, hospitals and patients to simplify assisted reproduction procedures, improve embryo quality, reduce risks and increase the success rates of fertility treatments with a more accessible, inclusive and effective solution.
- Sector
- Healthcare
- HQ
- Cordoba, Argentina
- Founded
- 2023
- Employees
- 5
- Website
- gameet.life/
- Ownership
- Privately Held (backing)
Gameet doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gameet shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gameet in its N-PORT filings yet. We sweep new filings monthly.